Metropolitan Life Insurance Company (MetLife)’s Factset FDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,536
Closed -$698K 752
2024
Q1
$698K Sell
1,536
-10
-0.6% -$4.66K 0.03% 412
2023
Q4
$738K Sell
1,546
-33
-2% -$14.8K 0.03% 382
2023
Q3
$690K Sell
1,579
-91
-5% -$38.8K 0.04% 371
2023
Q2
$669K Sell
1,670
-41
-2% -$16.5K 0.03% 400
2023
Q1
$710K Sell
1,711
-440
-20% -$183K 0.04% 391
2022
Q4
$863K Sell
2,151
-65
-3% -$27.7K 0.04% 393
2022
Q3
$887K Sell
2,216
-22
-1% -$9.31K 0.04% 379
2022
Q2
$861K Sell
2,238
-48
-2% -$18.8K 0.04% 397
2022
Q1
$992K Sell
2,286
-3,498
-60% -$1.48M 0.04% 419
2021
Q4
$2.81M Sell
5,784
-2,657
-31% -$1.19M 0.04% 387
2021
Q3
$3.33M Sell
8,441
-299
-3% -$109K 0.05% 310
2021
Q2
$2.93M Sell
8,740
-373
-4% -$122K 0.04% 360
2021
Q1
$2.81M Buy
9,113
+219
+2% +$69.3K 0.04% 368
2020
Q4
$2.96M Sell
8,894
-215
-2% -$71.1K 0.04% 343
2020
Q3
$3.05M Sell
9,109
-414
-4% -$143K 0.05% 293
2020
Q2
$3.13M Sell
9,523
-2,291
-19% -$662K 0.06% 279
2020
Q1
$3.08M Sell
11,814
-631
-5% -$172K 0.06% 260
2019
Q4
$3.34M Sell
12,445
-68
-0.5% -$17.5K 0.05% 315
2019
Q3
$3.04M Sell
12,513
-250
-2% -$69.4K 0.05% 314
2019
Q2
$3.66M Sell
12,763
-8
-0.1% -$2.21K 0.06% 270
2019
Q1
$3.17M Sell
12,771
-62
-0.5% -$13.9K 0.06% 282
2018
Q4
$2.57M Sell
12,833
-66
-0.5% -$14.5K 0.05% 316
2018
Q3
$2.89M Sell
12,899
-253
-2% -$54.9K 0.05% 337
2018
Q2
$2.61M Buy
13,152
+168
+1% +$33.6K 0.04% 376
2018
Q1
$2.59M Buy
12,984
+28
+0.2% +$5.66K 0.04% 388
2017
Q4
$2.5M Sell
12,956
-25,683
-66% -$4.93M 0.03% 416
2017
Q3
$6.96M Sell
38,639
-185
-0.5% -$30.2K 0.04% 381
2017
Q2
$6.45M Buy
38,824
+335
+0.9% +$54.8K 0.04% 419
2017
Q1
$6.35M Sell
38,489
-429
-1% -$75K 0.04% 443
2016
Q4
$6.36M Sell
38,918
-892
-2% -$142K 0.05% 429
2016
Q3
$6.45M Sell
39,810
-391
-1% -$67.4K 0.05% 403
2016
Q2
$6.49M Buy
40,201
+938
+2% +$145K 0.05% 392
2016
Q1
$5.95M Buy
39,263
+836
+2% +$125K 0.05% 422
2015
Q4
$6.25M Buy
38,427
+263
+0.7% +$44.2K 0.05% 396
2015
Q3
$6.1M Buy
38,164
+1,883
+5% +$308K 0.04% 405
2015
Q2
$5.9M Buy
36,281
+276
+0.8% +$44.8K 0.04% 454
2015
Q1
$5.73M Buy
36,005
+1,155
+3% +$173K 0.04% 461
2014
Q4
$4.91M Buy
34,850
+119
+0.3% +$15.8K 0.03% 549
2014
Q3
$4.22M Sell
34,731
-2
-0% -$247 0.03% 589
2014
Q2
$4.18M Sell
34,733
-371
-1% -$40.3K 0.03% 627
2014
Q1
$3.79M Buy
35,104
+393
+1% +$41.6K 0.03% 674
2013
Q4
$3.77M Sell
34,711
-49
-0.1% -$5.44K 0.03% 657
2013
Q3
$3.79M Buy
34,760
+253
+0.7% +$27.3K 0.03% 613
2013
Q2
$3.52M Buy
+34,507
New +$3.31M 0.03% 606

Other funds holding FDS

Metropolitan Life Insurance Company (MetLife)'s FDS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Factset (FDS) in Q2 2024, closing a stake of 1,536 shares — an estimated $698K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FDS in Q2 2013 and held it in 44 quarters. The position peaked at $6.96M in Q3 2017. 804 funds tracked by Wall St. Rank hold FDS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Factset position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,536 Factset shares in Q2 2024, an estimated $698K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Factset in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Factset position peaked at $6.96M in Q3 2017.
  • 804 funds tracked by Wall St. Rank held Factset as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.